Lacosamide Neuraxpharm (Lacosamide)

Lacosamide is an anticonvulsant used to manage focal seizure disorders.

• Partial‑onset seizures in adults: reduces seizure frequency when added to existing therapy.
• Partial‑onset seizures in adolescents (≥16 years): provides adjunctive seizure control in this age group.
• Refractory focal epilepsy: improves overall seizure management when other agents are insufficient.

• Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing hyperexcitable neuronal membranes and reducing repetitive neuronal firing. This selective modulation limits the propagation of epileptiform activity without significantly affecting normal neuronal conduction.

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Dizziness: sensation of light‑headedness or unsteadiness.
• Nausea: mild to moderate stomach upset.
• Fatigue: increased tiredness or lack of energy.
• Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm, especially in patients with pre‑existing conduction disorders.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Suicidal thoughts: emergence of depressive symptoms or suicidal ideation.
• Respiratory depression: marked reduction in breathing effort.
• Hepatic injury: signs of liver dysfunction including jaundice.

When prescribing Lacosamide, clinicians should consider several safety factors.

• Renal impairment: adjust dosing or monitor renal function closely.
• Hepatic impairment: use with caution in patients with liver disease.
• Cardiac conduction disorders: avoid in patients with known PR‑interval prolongation.
• Concomitant sodium‑channel blockers: monitor for additive effects on seizure control and cardiac rhythm.
• Pregnancy and breastfeeding: evaluate risk‑benefit ratio before use.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lacosamide can interact with other medicines, requiring attention to the interaction strength.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase lacosamide plasma levels.
• Strong CYP3A4 inducers (e.g., rifampin): may reduce lacosamide effectiveness.

Moderate Interactions (Monitor Closely):\n- Oral contraceptives: may experience reduced hormonal efficacy.

• Antihypertensives: potential additive blood‑pressure lowering effect.
• Anticoagulants: monitor for altered coagulation parameters.